Journal article icon

Journal article

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.

Abstract:

This paper in the series from the World Congress of Gastroenterology addresses the safety and immunogenicity of biological therapy. The safety profile in randomized controlled studies of all biological agents in Crohn's disease (CD) and ulcerative colitis has been generally favorable, but a small percentage of patients experience severe side effects on biological therapy, including pneumonia, tuberculosis, lymphoma, demyelination, drug-induced lupus, or hepatotoxicity. Although there is unequ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1038/ajg.2011.211

Authors


Expand authors...
Journal:
The American journal of gastroenterology
Volume:
106
Issue:
9
Pages:
1594-1603
Publication date:
2011-09-05
DOI:
EISSN:
1572-0241
ISSN:
0002-9270
URN:
uuid:3bed5228-a9ac-4a8a-b68d-4ef6395ef0a9
Source identifiers:
353561
Local pid:
pubs:353561

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP